News
Sanofi has agreed to invest up to $25m in Adagene, which will enable the latter to fund its research and development (R&D) ...
Detailed price information for Adagene Inc ADR (ADAG-Q) from The Globe and Mail including charting and trades.
UBS analyst Colin White maintained a Buy rating on Sanofi (SNYNF – Research Report) today. The company’s shares closed yesterday at $94.99. Don’t Miss TipRanks’ Half-Year ...
Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results